3/6
01:41 pm
pfe
Pfizer Obesity Nod In China And Cancer Wins Reframe Long Term Growth [Yahoo! Finance]
Low
Report
Pfizer Obesity Nod In China And Cancer Wins Reframe Long Term Growth [Yahoo! Finance]
3/5
12:40 pm
pfe
Moderna pays up to $2.25bn to settle drug delivery tech patent lawsuit [Yahoo! Finance]
Low
Report
Moderna pays up to $2.25bn to settle drug delivery tech patent lawsuit [Yahoo! Finance]
3/5
12:28 pm
pfe
Pfizer Bladder Cancer Trial Results Deepen Oncology Growth And Risk Debate [Yahoo! Finance]
Low
Report
Pfizer Bladder Cancer Trial Results Deepen Oncology Growth And Risk Debate [Yahoo! Finance]
3/5
10:04 am
pfe
A Look At Pfizer (PFE) Valuation As Long Term Returns And DCF Views Diverge [Yahoo! Finance]
Low
Report
A Look At Pfizer (PFE) Valuation As Long Term Returns And DCF Views Diverge [Yahoo! Finance]
3/5
06:10 am
pfe
Pfizer: Obesity Hype And Vaccine Policy Shocks [Seeking Alpha]
Low
Report
Pfizer: Obesity Hype And Vaccine Policy Shocks [Seeking Alpha]
3/4
09:16 pm
pfe
Argus Turns Bullish on Pfizer (PFE), Highlights GLP-1 and Oncology Pipeline [Yahoo! Finance]
Neutral
Report
Argus Turns Bullish on Pfizer (PFE), Highlights GLP-1 and Oncology Pipeline [Yahoo! Finance]
3/4
06:29 pm
pfe
Global Nanomedicine Market is Projected to Cross the USD 550 Billion Mark by 2034 as Advanced Drug Delivery Technologies Accelerate Adoption | DelveInsight [Yahoo! Finance]
Neutral
Report
Global Nanomedicine Market is Projected to Cross the USD 550 Billion Mark by 2034 as Advanced Drug Delivery Technologies Accelerate Adoption | DelveInsight [Yahoo! Finance]
3/4
10:20 am
pfe
Moderna will pay up to $2.25B to end COVID vaccine patent fight [Yahoo! Finance]
Low
Report
Moderna will pay up to $2.25B to end COVID vaccine patent fight [Yahoo! Finance]
3/4
09:09 am
pfe
ParaZero Strengthens Global Sales Leadership with Appointment of Bat-Sheva Noy as VP [Yahoo! Finance]
Low
Report
ParaZero Strengthens Global Sales Leadership with Appointment of Bat-Sheva Noy as VP [Yahoo! Finance]
3/3
02:58 pm
pfe
Spotting Winners: Viatris (NASDAQ:VTRS) And Generic Pharmaceuticals Stocks In Q4 [Yahoo! Finance]
Low
Report
Spotting Winners: Viatris (NASDAQ:VTRS) And Generic Pharmaceuticals Stocks In Q4 [Yahoo! Finance]
3/3
04:28 am
pfe
Pfizer Oncology Milestones Reshape Outlook Beyond COVID 19 Revenues [Yahoo! Finance]
Low
Report
Pfizer Oncology Milestones Reshape Outlook Beyond COVID 19 Revenues [Yahoo! Finance]
3/2
12:43 pm
pfe
Pfizer CEO flags issues with FDA's vaccine leadership [CNBC]
Low
Report
Pfizer CEO flags issues with FDA's vaccine leadership [CNBC]
3/2
12:43 pm
pfe
1 Reason I'd Happily Buy Pfizer (PFE) Stock and Never Sell [Yahoo! Finance]
Low
Report
1 Reason I'd Happily Buy Pfizer (PFE) Stock and Never Sell [Yahoo! Finance]
3/2
08:03 am
pfe
Pfizer (PFE) was upgraded by Argus from "hold" to "buy". They now have a $35.00 price target on the stock.
Low
Report
Pfizer (PFE) was upgraded by Argus from "hold" to "buy". They now have a $35.00 price target on the stock.
3/1
04:40 am
pfe
Pfizer Inc. (PFE) and Astellas Pharma Announce Positive Results From the Phase 3 EV-304 Clinical Trial for PADCEVTM [Yahoo! Finance]
Low
Report
Pfizer Inc. (PFE) and Astellas Pharma Announce Positive Results From the Phase 3 EV-304 Clinical Trial for PADCEVTM [Yahoo! Finance]
2/27
12:50 pm
pfe
One in Three Rheumatologists View BMS' Sotyktu as a Substantial Advance in Psoriatic Arthritis Ahead of March 6 FDA Decision, According to Spherix Global Insights Data [Yahoo! Finance]
Low
Report
One in Three Rheumatologists View BMS' Sotyktu as a Substantial Advance in Psoriatic Arthritis Ahead of March 6 FDA Decision, According to Spherix Global Insights Data [Yahoo! Finance]
2/27
10:21 am
pfe
PADCEV™ + Keytruda® Cuts Risk of Recurrence or Death by Nearly 50% in Cisplatin-Eligible Muscle-Invasive Bladder Cancer [Yahoo! Finance]
Low
Report
PADCEV™ + Keytruda® Cuts Risk of Recurrence or Death by Nearly 50% in Cisplatin-Eligible Muscle-Invasive Bladder Cancer [Yahoo! Finance]
2/27
10:00 am
pfe
PADCEV™ + Keytruda® Cuts Risk of Recurrence or Death by Nearly 50% in Cisplatin-Eligible Muscle-Invasive Bladder Cancer
Low
Report
PADCEV™ + Keytruda® Cuts Risk of Recurrence or Death by Nearly 50% in Cisplatin-Eligible Muscle-Invasive Bladder Cancer
2/27
07:20 am
pfe
Pfizer (PFE) Secures Full FDA Approval for BRAFTOVI as First-Line Treatment in mCRC [Yahoo! Finance]
Low
Report
Pfizer (PFE) Secures Full FDA Approval for BRAFTOVI as First-Line Treatment in mCRC [Yahoo! Finance]
2/26
10:39 pm
pfe
Love Dividends? 1 Stock to Buy Now With a Yield Over 6%. [Yahoo! Finance]
Low
Report
Love Dividends? 1 Stock to Buy Now With a Yield Over 6%. [Yahoo! Finance]
2/26
06:28 am
pfe
Pfizer (PFE) was upgraded by Royal Bank Of Canada to "strong sell".
Low
Report
Pfizer (PFE) was upgraded by Royal Bank Of Canada to "strong sell".
2/26
06:28 am
pfe
Pfizer (PFE) was upgraded by Zacks Research from "strong sell" to "hold".
Low
Report
Pfizer (PFE) was upgraded by Zacks Research from "strong sell" to "hold".
2/25
07:04 pm
pfe
The Bull Case For Pfizer (PFE) Could Change Following New First-Line BRAFTOVI Colorectal Cancer Approval [Yahoo! Finance]
Neutral
Report
The Bull Case For Pfizer (PFE) Could Change Following New First-Line BRAFTOVI Colorectal Cancer Approval [Yahoo! Finance]
2/25
05:58 pm
pfe
RFK Jr.'s CDC panel to discuss Covid vaccine injuries in upcoming meeting [MSNBC.com]
Low
Report
RFK Jr.'s CDC panel to discuss Covid vaccine injuries in upcoming meeting [MSNBC.com]
2/25
02:20 pm
pfe
ViiV Healthcare presents pipeline data for two investigational HIV treatment therapies with potential for twice-yearly dosing [Yahoo! Finance]
Low
Report
ViiV Healthcare presents pipeline data for two investigational HIV treatment therapies with potential for twice-yearly dosing [Yahoo! Finance]